Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cleocin Phosphate
2. Clindamycin-2-phosphate
3. Clindesse
4. Clindets
1. 24729-96-2
2. Cleocin Phosphate
3. Clindamycin 2-phosphate
4. Clindets
5. Cleocin T
6. Clindagel
7. Clindesse
8. Evoclin
9. Clinda-derm
10. Dalacin P
11. Clindamycin-2-phosphate
12. Clindamycin 2-dihydrogen Phosphate
13. Clindamycin (phosphate)
14. Dalacin T
15. 7(s)-chloro-7-deoxylincomycin 2-phosphate
16. U 28508
17. U-28508
18. U-28,508
19. Eh6d7113i8
20. Nsc 618653
21. Nsc-618653
22. Dsstox_cid_28603
23. Dsstox_rid_82873
24. Dsstox_gsid_48677
25. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Dihydrogen Phosphate
26. Clindamax
27. Evoclin (tn)
28. Dalacin-s (tn)
29. Clindamycin Injection
30. Cas-24729-96-2
31. Einecs 246-433-0
32. Clindamycin Phosphate Hydrate [jan]
33. Clindamycin Dihydrogenphosphat
34. Clinadac
35. Unii-eh6d7113i8
36. Clindamycin Phosphate Hydrate
37. Clindamycin Phosphate In Dextrose 5%
38. Clindamycin-2-dihydrogenphosphat
39. Ncgc00163494-01
40. Ncgc00166320-01
41. Clindamycin-phosphate
42. Clindac
43. Xaciato
44. Clindamycin Phosphate [usan:usp:jan]
45. Cleocin Phosphate In Dextrose 5% In Plastic Container
46. Clindamycin Phosphate In Dextrose 5% In Plastic Container
47. Schembl37148
48. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
49. Chembl3184512
50. Dtxsid1048677
51. Bdbm241975
52. Clindamycin (as Phosphate)
53. Clindamycin Phosphate (jp17/usp)
54. Clindamycin Phosphate [jan]
55. Hy-b1064
56. Zinc4102185
57. Clindamycin Phosphate [usan]
58. Tox21_113055
59. Tox21_113410
60. Clindamycin Phosphate (u-28508e)
61. Clindamycin Phosphate [vandf]
62. Mfcd11982855
63. S2048
64. Clindamycin Phosphate [mart.]
65. Akos008901431
66. Clindamycin Phosphate [usp-rs]
67. Clindamycin Phosphate [who-dd]
68. Clindamycin Phosphate [who-ip]
69. Ccg-269736
70. Clindamycin Phosphate System Suitability
71. Cs-4620
72. Ncgc00386379-01
73. As-12554
74. L-threo-alpha-d-galacto-octapyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
75. Methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, 2-(dihydrogen Phosphate)
76. Clindamycin Phosphate [orange Book]
77. Duac Component Clindamycin Phosphate
78. Clindamycin Phosphate [ep Monograph]
79. Clindamycin Phosphate For System Suitability
80. Ziana Component Clindamycin Phosphate
81. Acanya Component Clindamycin Phosphate
82. Clindamycin Phosphate [usp Monograph]
83. Clindamycini Phosphas [who-ip Latin]
84. Veltin Component Clindamycin Phosphate
85. Clindamycin Phosphate Component Of Duac
86. Benzaclin Component Clindamycin Phosphate
87. Clindamycin 2-dihydrogen Phosphate [mi]
88. Clindamycin Phosphate Component Of Ziana
89. D01073
90. Idp-126 Component Clindamycin Phosphate
91. Ab01566857_01
92. Clindamycin Phosphate Component Of Acanya
93. Clindamycin Phosphate Component Of Veltin
94. A817470
95. Clindamycin Phosphate Component Of Benzaclin
96. Sr-01000872581
97. Sr-01000872581-1
98. Brd-k27771035-001-02-5
99. Q27106184
100. Clindamycin Phosphate System Suitability [usp-rs]
101. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Dihydrogen Phosphate
102. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yldihydrogenphosphate
103. (2s-trans)-methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
104. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] Dihydrogen Phosphate
105. [(2r,4r,5r)-6-[(2s)-2-chloro-1-[[[(2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl]-oxomethyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)-3-oxanyl] Dihydrogen Phosphate
106. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-((((2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate)
107. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
108. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
| Molecular Weight | 505.0 g/mol |
|---|---|
| Molecular Formula | C18H34ClN2O8PS |
| XLogP3 | -1.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 504.1462019 g/mol |
| Monoisotopic Mass | 504.1462019 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 658 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 2 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 3 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 4 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 5 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 6 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
| 7 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 8 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 9 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 10 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 11 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 12 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Minakem is manufacturing small molecules APIs including corticosteroids
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13705
Submission : 1998-09-01
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13725
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-01-23
DMF Number : 14412
Submission : 1999-09-23
Status : Active
Type : II
Certificate Number : R1-CEP 2000-097 - Rev 05
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Status : Valid
Registration Number : 226MF10069
Registrant's Address : Mallorca, 262, 3rd floor 08008 Barcelona Spain
Initial Date of Registration : 2014-03-11
Latest Date of Registration : --
NDC Package Code : 49711-0116
Start Marketing Date : 2009-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-11-30
Pay. Date : 2016-08-02
DMF Number : 17422
Submission : 2004-05-09
Status : Active
Type : II
Certificate Number : CEP 2003-060 - Rev 07
Issue Date : 2024-03-25
Type : Chemical
Substance Number : 996
Status : Valid
NDC Package Code : 39635-0001
Start Marketing Date : 2014-03-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24358
Submission : 2010-11-08
Status : Active
Type : II
Certificate Number : R1-CEP 2011-019 - Rev 01
Issue Date : 2018-06-13
Type : Chemical
Substance Number : 996
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18533
Submission : 2005-07-22
Status : Inactive
Type : II
Certificate Number : R0-CEP 2003-177 - Rev 01
Issue Date : 2010-01-14
Type : Chemical
Substance Number : 996
Status : Expired
NDC Package Code : 49711-0116
Start Marketing Date : 2009-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE/ML
USFDA APPLICATION NUMBER - 50441
DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Fede...DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50537
DOSAGE - LOTION;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50600
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50615
DOSAGE - GEL;TOPICAL - 5%;1.2%
USFDA APPLICATION NUMBER - 50741
DOSAGE - GEL;TOPICAL - 5%;EQ 1% BASE
USFDA APPLICATION NUMBER - 50756
DOSAGE - SUPPOSITORY;VAGINAL - 100MG
USFDA APPLICATION NUMBER - 50767
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50782
DOSAGE - CREAM;VAGINAL - EQ 2% BASE
USFDA APPLICATION NUMBER - 50793
DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal...DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50801
DOSAGE - GEL;TOPICAL - 1.2%;0.025%
USFDA APPLICATION NUMBER - 50803
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Jai Radhe Sales
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Parenteral
Thickeners and Stabilizers
Film Formers & Plasticizers
Emulsifying Agents
Fillers, Diluents & Binders
Co-Processed Excipients
Coating Systems & Additives
Direct Compression
Surfactant & Foaming Agents
Controlled & Modified Release
Lubricants & Glidants
Taste Masking
Granulation
Rheology Modifiers
API Stability Enhancers
Chewable & Orodispersible Aids
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
